Companies / Surgery Partners, Inc. / Activity
Activity — Surgery Partners, Inc.
34 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Webb William Trenton Executive | Sell | Common Stock | $3.8K | -272 -0.36% | 74,249 0.06% of shares | low |
| Mar 5, 2026 | Webb William Trenton Executive | Sell | Common Stock | $24.9K | -2K -2.42% | 72,455 0.06% of shares | low |
| Mar 13, 2026 | Burkhalter Danielle Executive | Sell | Common Stock | $44.5K | -3K -4.32% | 76,864 0.06% of shares | low |
| Mar 13, 2026 | Brittenham Marissa Executive | Sell | Common Stock | $45.9K | -4K -3.74% | 94,196 0.07% of shares | low |
| Mar 12, 2026 | Baldock Jennifer Executive | Sell | Common Stock | $76.4K | -6K -1.75% | 326,474 0.25% of shares | low |
| Mar 6, 2026 | Burkhalter Danielle Executive | Sell | Common Stock | $105.2K | -8K -17.25% | 37,103 0.03% of shares | medium |
| Mar 16, 2026 | Doherty David T Executive | Sell | Common Stock | $110.8K | -9K -3.85% | 221,679 0.17% of shares | medium |
| Mar 6, 2026 | Brittenham Marissa Executive | Sell | Common Stock | $120.4K | -9K -13.85% | 54,623 0.04% of shares | medium |
| Mar 5, 2026 | Burkhalter Danielle Executive | Grant | Common Stock | $129.1K | +9K +12.85% | 80,333 0.06% of shares | low |
| Mar 5, 2026 | Brittenham Marissa Executive | Grant | Common Stock | $129.1K | +9K +10.32% | 97,853 0.07% of shares | low |
| Mar 6, 2026 | Baldock Jennifer Executive | Sell | Common Stock | $138.1K | -10K -2.94% | 332,272 0.25% of shares | medium |
| Mar 6, 2026 | Evans Jason Eric CEO | Sell | Common Stock | $158.1K | -11K -1.70% | 662,680 0.51% of shares | medium |
| Jun 5, 2026 | Dean Lloyd H Director | Grant | Common Stock | $160.0K | +12K | 11,670 <0.01% of shares | low |
| Jun 5, 2026 | Adlerz Clifford G Director | Grant | Common Stock | $160.0K | +12K +20.32% | 69,104 0.05% of shares | low |
| Jun 5, 2026 | Hendrix Blair E Director | Grant | Common Stock | $160.0K | +12K +170.09% | 18,531 0.01% of shares | low |
| Jun 5, 2026 | Turner Brent Director | Grant | Common Stock | $160.0K | +12K +15.58% | 86,594 0.07% of shares | low |
| Mar 5, 2026 | Webb William Trenton Executive | Grant | Common Stock | $161.4K | +11K +12.31% | 104,347 0.08% of shares | low |
| Mar 6, 2026 | Doherty David T Executive | Sell | Common Stock | $201.7K | -15K -14.10% | 88,803 0.07% of shares | medium |
| Mar 5, 2026 | Burkhalter Danielle Executive | Grant | Common Stock | $230.9K | +16K +29.85% | 71,183 0.05% of shares | low |
| Mar 5, 2026 | Brittenham Marissa Executive | Grant | Common Stock | $230.9K | +16K +22.62% | 88,703 0.07% of shares | low |
| Mar 5, 2026 | Burkhalter Danielle Executive | Grant | Common Stock | $250.0K | +18K +47.75% | 54,820 0.04% of shares | low |
| Mar 5, 2026 | Brittenham Marissa Executive | Grant | Common Stock | $250.0K | +18K +32.44% | 72,340 0.06% of shares | low |
| Mar 16, 2026 | Evans Jason Eric CEO | Sell | Common Stock | $254.4K | -20K -2.17% | 920,386 0.70% of shares | medium |
| Mar 5, 2026 | Webb William Trenton Executive | Grant | Common Stock | $288.6K | +20K +28.23% | 92,909 0.07% of shares | low |
| Mar 5, 2026 | Baldock Jennifer Executive | Grant | Common Stock | $322.8K | +23K +7.16% | 342,354 0.26% of shares | low |
| Mar 5, 2026 | Doherty David T Executive | Grant | Common Stock | $430.4K | +31K +15.25% | 230,546 0.18% of shares | low |
| Mar 5, 2026 | Baldock Jennifer Executive | Grant | Common Stock | $577.2K | +41K +14.69% | 319,479 0.24% of shares | low |
| Mar 5, 2026 | Baldock Jennifer Executive | Grant | Common Stock | $600.0K | +43K +18.01% | 278,570 0.21% of shares | low |
| Mar 5, 2026 | Oppenheimer Justin Robert Executive | Grant | Common Stock | $600.0K | +43K +54.70% | 120,259 0.09% of shares | low |
| Mar 5, 2026 | Doherty David T Executive | Grant | Common Stock | $769.6K | +55K +37.49% | 200,045 0.15% of shares | low |
| Mar 5, 2026 | Doherty David T Executive | Grant | Common Stock | $800.0K | +57K +63.85% | 145,500 0.11% of shares | low |
| Jan 13, 2026 | Oppenheimer Justin Robert Executive | Grant | Common Stock | $1.25M | +78K | 77,736 0.06% of shares | low |
| Mar 5, 2026 | Evans Jason Eric CEO | Grant | Common Stock | $1.92M | +136K +16.95% | 940,786 0.72% of shares | low |
| Mar 5, 2026 | Evans Jason Eric CEO | Grant | Common Stock | $2.00M | +142K +21.39% | 804,423 0.61% of shares | low |